Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Randomized-withdrawal, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension

NCT01515865 is registered in ClinicalTrials.gov with Shire as lead sponsor.

NCT NCT01515865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01515865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Randomized-withdrawal, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Clinical Benefit of Midodrine Hydrochloride in Male and Female Subjects With Symptomatic Orthostatic Hypotension
Lead sponsor
Shire
Phase
Phase 4
Overall status
Completed
Start date
May 23, 2012
Completion date
November 11, 2013
Enrollment
98 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

symptomatic orthostatic hypotension